Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.

Kirov II, Tal A, Babb JS, Herbert J, Gonen O.

Neurology. 2013 Jan 1;80(1):39-46. doi: 10.1212/WNL.0b013e31827b1a8c. Epub 2012 Nov 21.

2.

Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study.

Kirov II, Tal A, Babb JS, Lui YW, Grossman RI, Gonen O.

J Neurol. 2013 Jan;260(1):242-52. doi: 10.1007/s00415-012-6626-z. Epub 2012 Aug 12.

3.

MR spectroscopy indicates diffuse multiple sclerosis activity during remission.

Kirov II, Patil V, Babb JS, Rusinek H, Herbert J, Gonen O.

J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1330-6. doi: 10.1136/jnnp.2009.176263. Epub 2009 Jun 21.

4.

Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.

He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O.

Radiology. 2005 Jan;234(1):211-7. Epub 2004 Nov 4.

PMID:
15528260
5.

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.

Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, McLean MA, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.

J Neurol. 2006 Feb;253(2):224-30. Epub 2005 Nov 24.

PMID:
16307201
6.

Proton MR spectroscopy correlates diffuse axonal abnormalities with post-concussive symptoms in mild traumatic brain injury.

Kirov II, Tal A, Babb JS, Reaume J, Bushnik T, Ashman TA, Flanagan S, Grossman RI, Gonen O.

J Neurotrauma. 2013 Jul 1;30(13):1200-4. doi: 10.1089/neu.2012.2696.

7.

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.

Pascual AM, Martínez-Bisbal MC, Boscá I, Valero C, Coret F, Martínez-Granados B, Marti-Bonmati L, Mir A, Celda B, Casanova B.

Neurology. 2007 Jul 3;69(1):63-7.

PMID:
17606882
8.

Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Kirov II, Liu S, Fleysher R, Fleysher L, Babb JS, Herbert J, Gonen O.

Radiology. 2010 Mar;254(3):858-66. doi: 10.1148/radiol.09091015.

9.

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, Miller DH.

Brain. 2002 Oct;125(Pt 10):2342-52.

10.

Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS : a MRSI study.

Van Au Duong M, Audoin B, Le Fur Y, Confort-Gouny S, Malikova I, Soulier E, Viout P, Ali-Cherif A, Pelletier J, Cozzone PJ, Ranjeva JP.

J Neurol. 2007 Jul;254(7):914-23. Epub 2007 Apr 20.

PMID:
17446993
11.

Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis.

Oguz KK, Kurne A, Aksu AO, Karabulut E, Serdaroglu A, Teber S, Haspolat S, Senbil N, Kurul S, Anlar B.

AJNR Am J Neuroradiol. 2009 Apr;30(4):716-21. doi: 10.3174/ajnr.A1425. Epub 2009 Jan 15.

12.
13.

Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.

Hannoun S, Bagory M, Durand-Dubief F, Ibarrola D, Comte JC, Confavreux C, Cotton F, Sappey-Marinier D.

PLoS One. 2012;7(3):e32525. doi: 10.1371/journal.pone.0032525. Epub 2012 Mar 30. Erratum in: PLoS One. 2012;7(8): doi/10.1371/annotation/beed29e2-e61a-4d2f-8baa-ac53cf2fee7b.

14.

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, Antel JP, Wolfson C, Arnold DL.

Brain. 1998 Jan;121 ( Pt 1):103-13.

15.

Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.

Inglese M, Li BS, Rusinek H, Babb JS, Grossman RI, Gonen O.

Magn Reson Med. 2003 Jul;50(1):190-5.

PMID:
12815694
16.

Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Wu WE, Kirov II, Tal A, Babb JS, Milla S, Oved J, Weiner HL, Devinsky O, Gonen O.

Epilepsy Behav. 2013 May;27(2):319-25. doi: 10.1016/j.yebeh.2013.02.018. Epub 2013 Mar 22.

17.

Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.

Stromillo ML, Giorgio A, Rossi F, Battaglini M, Hakiki B, Malentacchi G, Santangelo M, Gasperini C, Bartolozzi ML, Portaccio E, Amato MP, De Stefano N.

Neurology. 2013 Jun 4;80(23):2090-4. doi: 10.1212/WNL.0b013e318295d707. Epub 2013 May 1.

PMID:
23635962
18.

Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

Adalsteinsson E, Langer-Gould A, Homer RJ, Rao A, Sullivan EV, Lima CA, Pfefferbaum A, Atlas SW.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1941-5.

19.

Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.

Auer DP, Schirmer T, Heidenreich JO, Herzog J, Pütz B, Dichgans M.

Neurology. 2001 Mar 13;56(5):635-42.

PMID:
11245716
20.

Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.

Inglese M, Ge Y, Filippi M, Falini A, Grossman RI, Gonen O.

Neuroimage. 2004 Apr;21(4):1825-9.

PMID:
15050603
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk